VBS 2025: Rapid Fire Medical Retina
Tianyu Liu, MD Associated Retinal Consultants, Royal Oak, MI Jeffrey Yu, MD Kellogg Eye Center, University of Michigan, Ann Arbor, MI Dr. Glenn Jaffe moderated a lively discussion with panelists…
Author: retina roundup team
VBS 2025: Surgical Retina Debates
Sandra Hoyek, MD and Melissa Yuan, MD Mass Eye and Ear, Boston MA The Surgical Retina Debates session at VBS 2025, moderated by Drs. Virgilio Morales Canton and Adrienne Scott,…
Macula Society 2025 – Fellowship Research Award Winner Dr. Rachana Haliyur
Rachana Haliyur, MD, PhD, a first year vitreoretinal fellow at the University of Michigan Kellogg Eye Center, was awarded the prestigious Evangelos S. Gragoudas Award at the 2025 Macula Society…
Angiogenesis 2025 – High Resolution OCT and Trial Results in AMD and DME using Migaldendranib
Spencer Barrett, MD Bascom Palmer Eye Institute, Miami, FL Novel Findings from High Res OCT Talk (Dr. Freund) Dr. K. Bailey Freund presented a talk on “Novel Findings from Innovative…
Angiogenesis 2025 – Results of the SALWEEN trial and Differential for Macular Atrophy
Michael Massengill, MD Bascom Palmer Eye Institute, Miami, FL Dr. Giovanni Staurenghi delivered an insightful presentation on the Differential Diagnosis of Macular Atrophy. He emphasized the importance of distinguishing age-related…
Angiogenesis 2025 – Results of the Golden and Verona Studies
Joseph Pecha, MD, MPH Bascom Palmer Eye Institute, Miami, FL Efficacy and Safety of Complement Factor B Antisense, IONIS-FB-LRx, in Geographic Atrophy due to Age-Related Macular Degeneration: Results of the…
ACRC/Macula 2025 – Special Topics in Retina, and Women in Retina Panel
Mary (Molly) Munsell Mass Eye & Ear Special Topics in Retina for 2025 In the last session of MACULA 2025, Drs. Lee Jampol and Dr. Joseph Anaya moderated presentations on…
ACRC/Macula 2025 – Ocular Oncology
Stephanie Zhang Richmond Woodward Mass Eye & Ear The ocular oncology session began with a presentation on radiation retinopathy given by Dr. Arun Singh. Radiation retinopathy responds to anti-VEGF agents…